View More Recent Stories

Jul 10, 2024 07:35AM TD Cowen Reiterates Buy Rating on Arcutis Biotherapeutics Inc. (ARQT)

Jul 9, 2024 04:54PM Arcutis Biotherapeutics (ARQT) Announces FDA Approval of ZORYVE Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children above 6

Jul 9, 2024 08:43AM Mizuho Reiterates Outperform Rating on Arcutis Biotherapeutics Inc. (ARQT)

Jun 13, 2024 02:19PM Arcutis Biotherapeutics (ARQT) spreader active in July 10 and 12.50 calls

Jun 10, 2024 02:31PM Arcutis Biotherapeutics (ARQT) Announces New Long-Term Data of Roflumilast Cream 0.15%

View More Recent Stories